Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on November 3, 2009
[Cancer Research, 10.1158/0008-5472.CAN-09-0550]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-09-0550v1
69/22/8718    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Rincon-Orozco, B.
Right arrow Articles by Rösl, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rincon-Orozco, B.
Right arrow Articles by Rösl, F.

Epigenetic Silencing of Interferon-{kappa} in Human Papillomavirus Type 16–Positive Cells

Bladimiro Rincon-Orozco1, Gordana Halec2, Simone Rosenberger1, Dorothea Muschik1, Ingo Nindl1, Anastasia Bachmann3, Tina Maria Ritter1, Bolormaa Dondog4, Regina Ly1, Franz X. Bosch2, Rainer Zawatzky1 and Frank Rösl1

1 Angewandte Tumorvirologie, Abteilung Virale Transformationsmechanismen, Deutsches Krebsforschungszentrum, Universität Heidelberg; 2 Molekularbiologisches Labor, Universitäts-HNO-Klinik Heidelberg; 3 Molecular Alcohol Research in Gastroenterology, Universität Heidelberg; and 4 Angewandte Tumorvirologie, Abteilung Genomveränderungen und Karzinogenese, Deutsches Krebsforschungszentrum, Heidelberg, Germany

Requests for reprints: Frank Rösl, Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany. Phone: 49-6221-42-4900; Fax: 49-6221-42-4902; E-mail: f.roesl{at}DKFZ.de.

We have investigated interferon-{kappa} (IFN-{kappa}) regulation in the context of human papillomavirus (HPV)–induced carcinogenesis using primary human foreskin keratinocytes (HFK), immortalized HFKs encoding individual oncoproteins of HPV16 (E6, E7, and E6/E7), and cervical carcinoma cells. Here, IFN-{kappa} was suppressed in the presence of E6, whereas its expression was not affected in HFKs or E7-immortalized HFKs. Transcription could be reactivated after DNA demethylation but was decreased again upon drug removal. Partial reactivation could also be accomplished when E6 was knocked down, suggesting a contribution of E6 in IFN-{kappa} de novo methylation. We identified a single CpG island near the transcriptional start site as being involved in selective IFN-{kappa} expression. To prove the functional relevance of IFN-{kappa} in building up an antiviral response, IFN-{kappa} was ectopically expressed in cervical carcinoma cells where protection against vesicular stomatitis virus–mediated cytolysis could be achieved. Reconstitution of IFN-{kappa} was accompanied by an increase of p53, MxA, and IFN-regulatory factors, which was reversed by knocking down either IFN-{kappa} or p53 by small interfering RNA. This suggests the existence of a positive feedback loop between IFN-{kappa}, p53, and components of IFN signaling pathway to maintain an antiviral state. Our in vitro findings were further corroborated in biopsy samples of cervical cancer patients, in which IFN-{kappa} was also downregulated when compared with normal donor tissue. This is the first report showing an epigenetic silencing of type I IFN after HPV16 oncogene expression and revealing a novel strategy on how high-risk HPVs can abolish the innate immune response in their genuine host cells. [Cancer Res 2009;69(22):8718–25]

Key Words: innate immunity • de novo DNA methylation • antiviral activity • cervical cancer • immune escape







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.